COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine.

MLA

Bosia, Marta, et al. “COMT Val158Met and 5-HT1A-R -1019 C/G Polymorphisms: Effects on the Negative Symptom Response to Clozapine.” Pharmacogenomics, vol. 16, no. 1, Jan. 2015, pp. 35–44. EBSCOhost, https://doi.org/10.2217/pgs.14.150.

APA

Bosia, M., Lorenzi, C., Pirovano, A., Guglielmino, C., Cocchi, F., Spangaro, M., Bramanti, P., Smeraldi, E., & Cavallaro, R. (2015). COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. Pharmacogenomics, 16(1), 35–44. https://doi.org/10.2217/pgs.14.150

Chicago

Bosia, Marta, Cristina Lorenzi, Adele Pirovano, Carmelo Guglielmino, Federica Cocchi, Marco Spangaro, Placido Bramanti, Enrico Smeraldi, and Roberto Cavallaro. 2015. “COMT Val158Met and 5-HT1A-R -1019 C/G Polymorphisms: Effects on the Negative Symptom Response to Clozapine.” Pharmacogenomics 16 (1): 35–44. doi:10.2217/pgs.14.150.